Paul R. Edick, See Remarks at XERIS PHARMACEUTICALS INC (XERS), bought 35,870 shares at $8.55 ($307K) on 2019-11-25, disclosed to the SEC on 2019-11-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.55 | 17,935 | $153K | 50.0% |
| 2 | $8.55 | 17,935 | $153K | 50.0% |
| Total | $8.55 avg | 35,870 | $307K | 100% |
| Filing → |
| XERS | BUY | 2022-05-13 | $140K | — | Filing → |
| XERS | BUY | 2021-11-16 | $46K | — | Filing → |
| XERS | BUY | 2021-11-12 | $416K | — | Filing → |